Observational studyAnnals of medicine
Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study.
Open access · greenAbstract readComparative StudyMulticenter StudyObservational Study
In one paragraph
Observational study in Annals of medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022Guideline
- DPP4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.Advances in therapy · 2020Pooled it
- Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial).Acta diabetologica · 2023 · on this mapTrial
- Perioperative screening and management of hyperglycemia: a joint position statement from the Brazilian Diabetes Society (SBD), the Brazilian Society of Anesthesiology (SBA) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO).Diabetology & metabolic syndrome · 2026Review
- Random Blood Glucose: Episode 1.Clinical diabetes : a publication of the American Diabetes Association · 2025Review
- 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2025.Diabetes care · 2025Review
- Treatment of Diabetes in Hospitals With Noninsulin Medications Is a Research Priority.Diabetes care · 2024Article
- 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.Diabetes care · 2024Review
- Efficacy and safety of basal-bolus insulin at 1:1.5 ratio compared to 1:1 ratio using a weight-based initiation and titration (WIT2) algorithm in hospitalized patients with type 2 Diabetes: a multicenter, randomized, clinical study.Diabetology & metabolic syndrome · 2023Article
- 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.Diabetes care · 2023Review
- Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices.Current diabetes reports · 2022Review
- Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal-Bolus Insulin Regimen: A Prospective Randomized Study.Journal of clinical medicine · 2022Article
- Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure.Journal of clinical medicine · 2021Article
- Inpatient Hyperglycemia Management and COVID-19.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021Review
- Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.The American journal of the medical sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 1 country.
Luis M Pérez-Belmontea Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Málaga , Spain.
Julio Osuna-Sánchezd Servicio de Medicina Interna , Hospital Comarcal de Melilla , Melilla , Spain.
Mercedes Millán-Gómezb Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV) , Instituto de Salud Carlos III , Madrid , Spain.
María D López-Carmonaa Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Málaga , Spain.
Juan J Gómez-Doblasb Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV) , Instituto de Salud Carlos III , Madrid , Spain.
Lidia Cobos-Palaciosa Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Málaga , Spain.
Jaime Sanz-Cánovasa Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Málaga , Spain.
Miguel A Barbanchoc Unidad de Neurofisiología Cognitiva, Centro de Investigaciones Médico Sanitarias (CIMES), Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Campus de Excelencia Internacional (CEI) Andalucía Tech , Málaga , Spain.
José P Larac Unidad de Neurofisiología Cognitiva, Centro de Investigaciones Médico Sanitarias (CIMES), Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Campus de Excelencia Internacional (CEI) Andalucía Tech , Málaga , Spain.
Manuel Jiménez-Navarrob Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV) , Instituto de Salud Carlos III , Madrid , Spain.
M Rosa Bernal-Lópeza Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Málaga , Spain.
Ricardo Gómez-Huelgasa Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA) , Universidad de Málaga (UMA) , Málaga , Spain.
Hospital Regional Universitario de Málaga · ESUniversidad de Málaga · ESInstituto de Investigación Biomédica de Málaga · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital Comarcal de Inca · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AgedBlood GlucoseDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsDrug Therapy, CombinationFemaleGlycated HemoglobinHospitalizationHumansHypoglycemiaHypoglycemic AgentsInsulinLinagliptinMaleMiddle AgedSafetyBlood GlucoseDipeptidyl-Peptidase IV InhibitorsGlycated HemoglobinHypoglycemic AgentsInsulinLinagliptinDiabetes mellitusinpatient hyperglycaemialinagliptinnon-cardiac surgery
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.